---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-000342"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2022-01-20T23:59:59+00:00"
generated_at: "2026-06-27T16:46:39.928773+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sonoma Pharmaceuticals enters two distribution deals for Microcyn products

## Summary
- Non-exclusive distribution with Salus Medical for Microcyn dental/derm/wound/eye care in US; one-year initial term.
- Exclusive license to Anlicare for dental/oral products in China and Macau; five-year term after regulatory approval.
- Anlicare pays milestones-based royalties; must obtain regulatory licenses within two years or deal terminates.
- Salus can sell via own website only; no third-party platforms like Amazon.

## SEC filing metadata
- accession: 0001683168-22-000342
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2022-01-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316822000342/0001683168-22-000342-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316822000342/snoa_i8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-000342
- JSON: https://secwatch.observer/filing/0001683168-22-000342.json
- Plain text: https://secwatch.observer/filing/0001683168-22-000342.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.